Scientists develop inorganic resins for generating and purifying radium and actinium

Research advances the chemistry and improves the purity of isotopes for targeted alpha therapy used in the treatment of cancers.

2023-06-07

(Press-News.org) The Science Targeted alpha therapy can destroy cancerous cells without harming healthy cells. It’s especially useful for treating metastasized cancers. The Department of Energy (DOE) Office of Science’s Isotope Program is developing and marketing novel radioactive isotopes for targeted alpha therapy. One method of making one isotope, actinium-225, involves bombarding radium targets with neutrons. This method poses a challenge: how to chemically separate the radium from the actinium. This can destroy typical separation equipment due to a radioactive process called alpha decay. Now, researchers have investigated the use of radiation-resistant inorganic resin scaffolds as platforms for separating radium, actinium, and lead.

The Impact Demand and production of actinium-225 (Ac-225) and other alpha-emitting radioisotopes are increasing. These new types of resins will support the purification and distribution of these lifesaving isotopes. As production increases, radiation levels will also increase. Chemical processes need to be robust in these hazardous environments. These new resins and this recent research will help producers save time, effort, and costs while reducing the risks of manufacturing alpha-emitting radioisotopes.

Summary This research by scientists at Argonne National Laboratory explored new materials that could support and facilitate the efficient separation of radium and actinium in the context of the large-scale production of radioisotopes used in targeted alpha therapy. While these radioisotopes have the potential to produce powerful results in the treatment of cancers, scaling up production to meet the high demand of these radioisotopes comes with increasing radiation levels. This creates new sets of challenges, particularly radiation damage to process equipment.

The researchers explored this new class of radiation-resistant materials with respect to the fundamental radiochemical separations of radium, actinium, and lead. Through rigorous screening based on separation efficiency and chemical durability, they ultimately determined that zirconium-based materials are the optimal platform. The results demonstrated good separation capabilities of radium from actinium along with remarkable radiopurities using relatively simple chemicals. These efforts advance the DOE Isotope Program and its mission to conduct research and development on new and improved isotope production and processing for high-priority, cancer-fighting radioisotopes.

Funding This research is supported by the DOE Isotope Program, managed by the DOE Office of Science for Isotope R&D and Production.

END

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

New research: Maybe crying in baseball is a good thing?

2023-06-07

ITHACA, N.Y. – Venturing out of one’s comfort zone to perform a task – and then performing poorly in that task, such as a baseball pitcher trying to hit – can lead to better performance when returning to one’s specialty, according to new research. Brittany Bond, an assistant professor of organizational behavior in the Cornell School of Industrial and Labor Relations, and Ethan J. Poskanzer of the University of Colorado argue that this phenomenon occurs through a process they call “forced task inferiority,” in which underperformance in tasks outside their specialty frustrates ...

Electronic health records can contain bias, potentially impacting clinical trials

2023-06-07

Results of clinical trials are only as good as the data upon which they rest. This is especially true in terms of diversity — if most people in a trial are from a certain race or socioeconomic group, then the results may not be broadly applicable. This form of potential bias is not a novel concept. But a group of researchers at the University of Illinois Chicago and colleagues have identified a potential hidden source of bias: electronic health records. In a recent Contemporary Clinical ...

Yale-led study shows ‘significant overall survival benefit’ when lung-cancer drug is taken after surgery

2023-06-07

New Haven, Conn. — A clinical trial led by Yale Cancer Center shows that the drug osimertinib, a targeted therapy for non-small cell lung cancer, improved rates of survival and reduced risk of recurrence in patients after surgery. The results, published June 4 in the New England Journal of Medicine, were presented this week by Dr. Roy Herbst, deputy director of Yale Cancer Center and principal investigator of the ADAURA Phase III clinical trial, during the 2023 annual meeting of the American Society of Clinical Oncology. Herbst is also assistant dean for translational research, ensign professor of medicine (medical oncology), ...

Temptation at the checkout: 70% of food, drinks within arm’s reach are unhealthy

2023-06-07

We’ve all been there: waiting in line at a store checkout, surrounded by tempting snacks and drinks. Navigating the checkout lane in search of healthy options could be a challenge, according to researchers at the University of California, Davis, who found that 70% of foods and beverages at checkout are unhealthy. For snack-sized options, an even higher proportion were unhealthy — 89%. A study published this month in the journal Current Developments in Nutrition suggests most food and beverage options at checkout consist of candy (31%), sugar-sweetened beverages (11%), salty snacks (9%) and sweets (6%). Healthy ...

Devastating heart condition can be reversed, study shows for the first time

2023-06-07

Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College London) and the Royal Free Hospital. The condition, a form of amyloidosis affecting the heart, is progressive and has until now been seen as irreversible, with half of patients dying within four years of diagnosis. The new study, published as a letter in The New England Journal of Medicine, reports ...

DNAmFitAge: Biological age indicator incorporating physical fitness

2023-06-07

“We expect DNAmFitAge will be a useful biomarker for quantifying fitness benefits at an epigenetic level and can be used to evaluate exercise-based interventions.” BUFFALO, NY- June 7, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 10, entitled, “DNAmFitAge: biological age indicator incorporating physical fitness.” Physical fitness is a well-known correlate of health and the aging ...

Now is already too late – The European and international endocrine community calls for immediate action on chemicals legislation is the only way forward to address Endocrine Disrupting Chemicals

2023-06-07

Brussels, Belgium 7 June 2023 – The call for action reverberated across the halls of the European Parliament as a diverse group of scientists, policy makers and interest organisations gathered in a packed room, to discuss how to address the gaps between science and legislation and "Shape an ambitious legislative framework for endocrine disruptors." “Through such meetings with experts, we as policy makers can obtain valuable insight into the latest available science and benefit from it in our legislative ...

Trouble falling asleep, staying asleep linked to increased risk of stroke

2023-06-07

MINNEAPOLIS – People who have insomnia symptoms such as trouble falling asleep, staying asleep and waking up too early, may be more likely to have a stroke, according to a study published in the June 7, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. In addition, researchers found the risk was much higher in people under 50 years old. The study does not prove that insomnia symptoms cause stroke; it only shows an association. “There are many therapies that can help people improve the quality of their sleep, so determining which sleep ...

Seizures while driving and why it’s important to diagnose epilepsy ASAP

2023-06-07

MINNEAPOLIS – Prior to being diagnosed with epilepsy, 5% of people with a type of epilepsy called focal epilepsy had a seizure while driving, according to a new study published in the June 7, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. Focal epilepsy accounts for more than half of all cases of epilepsy. People with this form of epilepsy have recurring seizures that affect one half of the brain. “Seizures while driving pose substantial risks for those experiencing them and for others ...

Creating less-allergenic shrimp using pressure and steam

2023-06-07

With the start of summer, many people will be firing up their grills and roasting everything from hot dogs to steaks. Shrimp won’t be on the menu for millions of Americans with seafood allergies, though a method reported in ACS’ Journal of Agricultural and Food Chemistry could change that. The researchers say that reverse-pressure sterilization can produce a less-allergenic shrimp product that, when tested in mice sensitive to the crustaceans, did not cause severe reactions. Some of the most common foods that people are allergic to are dairy products, wheat, peanuts and seafood. The immune system mistakes some proteins from these foods for an intruder and ...

LAST 30 PRESS RELEASES:

Amid record year for dengue infections, new study finds climate change responsible for 19% of today’s rising dengue burden

New study finds air pollution increases inflammation primarily in patients with heart disease

AI finds undiagnosed liver disease in early stages

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski